Unsere Webseite verwendet Cookies, um Ihnen einen optimalen Service zu bieten. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden. Learn more OK
Roche Menü Suchen Global Web Site : Investors

You are here:

  1. Investors
  2. Investor updates
Roche
  • Home
  • Über Roche
  • Produkte
  • Nachhaltigkeit
  • Forschung und Entwicklung
  • Partnering
  • Medien
  • Investors
  • Karriere
  • Annual Report 2019
  • Quartalsergebnisse Archiv
  • Finance information tool
  • Pipeline
  • Diagnostics news
  • Sustainability download center
  • Dividend calendar
  • Total return center
  • Häufig gestellte Fragen
  • US investors
  • Contacts
  • Investor updates
  • IR events
  • Share price

Investor updates

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
Published on: 12 Januar 2021

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

mehr
Published on: 12 Januar 2021

Roche to present updated data confirming Tecentriq in combination with Avastin substantially improves overall survival in people with the most common form of liver cancer

mehr
Published on: 11 Januar 2021

Save the date: Roche Diagnostics Investor Day 2021 - Tuesday 23rd March 2021

mehr
Published on: 11 Januar 2021

Roche launches two digital pathology image analysis algorithms for precision patient diagnosis in breast cancer

mehr
Published on: 11 Januar 2021

Roche’s Xofluza approved by the European Commission for the treatment of influenza, the first new influenza antiviral for patients in almost 20 years

mehr
Published on: 5 Januar 2021

Invitation to Roche’s Full Year Results 2020 Presentation

mehr
Published on: 5 Januar 2021

Roche’s novel anti-TIGIT tiragolumab granted FDA Breakthrough Therapy Designation in combination with Tecentriq for PD-L1-high non-small cell lung cancer

mehr
Teilen
  • Via Email teilen
  • Auf Facebook teilen
  • Auf Twitter teilen
  • Auf LinkedIn teilen
  • Auf Google+ teilen
  • Auf Xing teilen
Schließen

Services

  • Investor Relations team
  • E-Mail senden
  • Roche Investor updates abonnieren
  • Roche Finance Info System

  • © 2021 F. Hoffmann-La Roche Ltd
  • 16.01.2021
  • Rechtliche Hinweise
  • Datenschutz
  • Cookie Settings

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

  • LinkedIn
  • Facebook
  • Pinterest
  • Twitter
  • YouTube